What the Medical Examiner Said as Levi Trial Heads to Closing Statements
This article reviews the medical examiner testimony cannabis evidence presented during the Levi trial. The clinical commentary highlights the importance of toxicology findings in legal medicine. Understanding this testimony is crucial for evidence-based…
Clinical Implications of Real-World Evidence from the CARE Study [Response to Letter]
Clinical implications real world evidence from the CARE study provide valuable insights into medical cannabis outcomes. This research bridges gaps left by controlled trials by capturing diverse patient experiences. Understanding this evidence helps…
New Study Highlights Cannabis Impairment and Clinical Evidence
This article discusses cannabis impairment evidence-based medicine from a recent Washington State University study. The study highlights clinical relevance in assessing cannabis use impairment. Understanding this evidence is crucial for informed clinical…
CBD Shows Promise But Lacks Broad Regulatory Approval: A Sobering Review of the Evidence
The CBD pharmacology regulatory context reveals a narrow evidence base supporting broad approval. Most CBD products lack pharmaceutical-grade quality and regulatory endorsement. This 2024 review highlights the need for rigorous clinical trials and…
Most European Countries Lack Evidence-Based Cannabis-Specific Treatment
Cannabis-specific treatment programs Europe remain limited and often lack evidence-based approaches. This 2025 overview reveals fragmented services with insufficient coverage. Structured psychosocial interventions are the most supported treatments for…
Bridging the Regulatory Chasm in Investigator‐Initiated Cannabis Research
Investigator initiated cannabis research barriers limit clinical studies and evidence-based medicine. Regulatory challenges impede rigorous cannabis research needed for informed decisions. Understanding these barriers is key to advancing cannabis…
WJBF – New Study Highlights Cannabis Safety Clinical Guidelines
This article discusses cannabis safety clinical guidelines based on a new study from Washington State University. The research holds high clinical relevance for evidence-based medicine. Understanding these guidelines is essential for informed clinical…
CBC Windsor’s Thursday Morning Cannabis News Update
This Thursday morning update covers the latest cannabis news clinical research with notable emerging findings. The report highlights evidence-based medicine and clinical research developments. Clinicians are encouraged to review detailed clinical data…
2 Reasons to Like THC and 1 to Stay Skeptical – The Globe and Mail
This clinical summary THC holdings clarifies the difference between financial market analysis and medical cannabis research. Patients often confuse investment news with clinical evidence. Clinicians should guide patients to focus on peer-reviewed studies…
Randomised Controlled Trial Evidence on Medicinal Cannabis for Treatment of Mental Health and Substance Use Disorders: A Scoping Review.
This scoping review synthesizes randomised controlled trial evidence medicinal cannabis for treating mental health and substance use disorders. The review addresses previous limitations in study design and quality. It provides clinicians with a clearer…